How Many Units Are in 5mg Semaglutide — and Why the Question Is Trickier Than It Looks

The misconception driving most of these searches: semaglutide does not work like insulin

When people type 'how many units in 5mg semaglutide', they are almost always thinking of the way insulin is measured, where 100 units per ml is a familiar standard and syringes are marked accordingly. Semaglutide has no equivalent unit convention. It is expressed purely in milligrams. So there is no official answer to 'how many units in 5mg semaglutide' because the question applies a framework that does not exist for this medicine.

Where the confusion becomes clinically important is when someone has obtained, or is considering, a 5mg/2ml compounded vial and is trying to draw doses using an insulin syringe. On a standard U-100 insulin syringe, the barrel markings read in units (where 1 unit = 0.01ml). At a concentration of 5mg/2ml (2.5mg per ml), a 0.25mg dose would sit at 10 units on that syringe, but this calculation only holds for that exact concentration, and a small measuring error at home produces a proportionally large dose error. The NHS semaglutide information page is clear that dose changes must be guided by a clinician; self-adjusting from a concentration table is not the same thing.

Licensed Wegovy pens sidestep all of this entirely. The dose is pre-set inside the pen. You click, inject, and discard the pen cap. Nothing is drawn, nothing is calculated.

What a 5mg/2ml concentration actually tells you, and what it does not

If you are looking at a vial labelled 5mg/2ml, the concentration is 2.5mg per ml. That is the only fact the label gives you with certainty. It does not tell you what dose you should take, how often, or how to measure it safely at home.

To put the milligram-to-volume figures in context: the licensed Wegovy injection schedule, as described in the product's summary of product characteristics on the electronic Medicines Compendium (eMC), starts at 0.25mg weekly for four weeks and steps up through 0.5mg, 1mg, 1.7mg, and 2.4mg, each step typically lasting around four weeks under prescriber guidance. The newer 7.2mg maintenance dose follows the same titration principle. At no point in that schedule does a patient need to calculate volumes; the pen handles it.

For anyone using a syringe and a vial, the practical maths at 2.5mg/ml concentration would be: 0.25mg = 0.1ml, 0.5mg = 0.2ml, 1mg = 0.4ml. On a U-100 insulin syringe those volumes correspond to 10, 20, and 40 units respectively, and if you want to understand how many mg 40 units of semaglutide works out to, our dedicated page explains that conversion in full. If you want to understand what 20 units of semaglutide works out to in milligrams, our page walking through that specific conversion explains the relationship clearly. The deeper question (whether using a vial at all is appropriate) is separate from the maths, and it matters more.

Why vial-based semaglutide sits outside the UK licensed supply chain

Compounded semaglutide vials are not licensed medicines in the UK. Wegovy, as a pre-filled pen, is the only semaglutide product licensed for weight management here. The MHRA has warned publicly about unlicensed and falsified weight-loss medicines being sold online; counterfeit pens have been seized in significant quantities, and some contained insulin rather than semaglutide, with predictable consequences for people who injected them expecting a GLP-1 medicine.

This is not a theoretical risk. It is why the question 'how many units do I draw' is one our prescribers regard as a warning sign. If someone is calculating units from a concentration table, it usually means they are not using a licensed product and do not have clinical oversight of their dosing. That combination is dangerous regardless of where the maths ends up.

If cost is the reason someone has turned to a compounded vial, it is worth knowing that the full cost picture for licensed treatment, including consultation and aftercare, is often closer to unofficial sources than it first appears. Our treatment page sets out exactly what is included in a private prescription through nume. If you have questions about the Wegovy dose schedule in detail, our page on Wegovy doses covers the full milligram ladder with the clinical context behind each step.

Switching to a licensed pen if you have been using a vial

Patients occasionally come to us having already used compounded semaglutide and wanting to transfer to a licensed product. That is possible, and a prescriber will review where you are in the titration sequence based on evidence of your current dose, not a self-reported unit figure. The prescription process does not simply continue from whatever dose you were drawing; a clinician assesses your current weight, tolerance, and history before confirming what step is appropriate.

The practical transition also has a storage difference worth noting. Licensed Wegovy pens need to be kept refrigerated between 2°C and 8°C (in the fridge door is a natural spot) until first use. A compounded vial stored at room temperature is outside licensed storage conditions from the start. Details on the licensed pen's exact storage window, and what to do if it has been left out, are in the Patient Information Leaflet that comes with the medicine; the eMC listing holds the full SmPC. If you are considering the switch, our Wegovy overview page gives a clear starting point, and you can see how the licensed UK dose schedule differs from vial-based approaches at our semaglutide 5mg/2ml dosage chart page. To understand the relationship between the 2.4mg maintenance dose and its unit equivalent, our page on 2.4mg semaglutide in units works through that specific conversion clearly.

Speak to our prescribers if you want to move onto a licensed, clinically supervised treatment. A same-day review from a real clinician is the starting point, no calculation required on your part.